Trading Report: Today, State Treasurer State of Michigan decides to keep it stake in Clorox Co. (CLX) to the level of $5,654,000

Today, State Treasurer State of Michigan decides to keep it stake in Clorox Co. (CLX) to the level of $5,654,000

State Treasurer State of Michigan boosted its position in Clorox Co. (NYSE:CLX) by 0.4% during the third quarter, according to its most recent 13F filing with the SEC. The firm owned 45,170 shares of the company’s stock after buying an additional 200 shares during the period. State Treasurer State of Michigan’s holdings in Clorox were worth $5,654,000 as of its most recent filing with the SEC.

Other large investors have also recently modified their holdings of the company. Fulton Breakefield Broenniman LLC boosted its stake in shares of Clorox by 0.8% in the second quarter. Fulton Breakefield Broenniman LLC now owns 77,919 shares of the company’s stock worth $10,783,000 after buying an additional 619 shares during the last quarter. First Republic Investment Management Inc. boosted its stake in shares of Clorox by 5.7% in the first quarter. First Republic Investment Management Inc. now owns 200,233 shares of the company’s stock worth $25,242,000 after buying an additional 10,868 shares during the last quarter. Boston Advisors LLC boosted its stake in shares of Clorox by 14.3% in the second quarter. Boston Advisors LLC now owns 196,360 shares of the company’s stock worth $27,174,000 after buying an additional 24,501 shares during the last quarter. Sabal Trust CO boosted its stake in shares of Clorox by 2.9% in the second quarter. Sabal Trust CO now owns 163,636 shares of the company’s stock worth $22,645,000 after buying an additional 4,571 shares during the last quarter. Finally, Blair William & Co. IL boosted its stake in shares of Clorox by 13.4% in the second quarter. Blair William & Co. IL now owns 149,783 shares of the company’s stock worth $20,728,000 after buying an additional 17,714 shares during the last quarter. 69.90% of the stock is currently owned by institutional investors and hedge funds.

Clorox Co. (NYSE:CLX) traded up 1.51% on Friday, hitting $117.22. The stock had a trading volume of 448,683 shares. The stock’s 50 day moving average is $117.63 and its 200 day moving average is $127.59. Clorox Co. has a one year low of $111.24 and a one year high of $140.47. The stock has a market cap of $15.09 billion, a price-to-earnings ratio of 23.60 and a beta of 0.36.

Clorox (NYSE:CLX) last released its earnings results on Wednesday, November 2nd. The company reported $1.36 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $1.42 by $0.06. The company earned $1.44 billion during the quarter, compared to analyst estimates of $1.24 billion. Clorox had a net margin of 11.27% and a return on equity of 250.82%. The company’s revenue for the quarter was up 3.8% on a year-over-year basis. During the same period in the previous year, the firm posted $1.32 EPS. Analysts anticipate that Clorox Co. will post $5.32 earnings per share for the current year.

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, February 10th. Investors of record on Wednesday, January 25th will be issued a dividend of $0.80 per share. This represents a $3.20 dividend on an annualized basis and a yield of 2.73%. The ex-dividend date is Monday, January 23rd. Clorox’s dividend payout ratio is presently 64.26%.

A number of brokerages have recently issued reports on CLX. Zacks Investment Research upgraded Clorox from a “sell” rating to a “hold” rating in a research report on Friday, November 18th. Wells Fargo & Co. reiterated a “market perform” rating on shares of Clorox in a research report on Tuesday, November 15th. B. Riley reiterated a “neutral” rating and set a $111.00 target price on shares of Clorox in a research report on Monday, November 14th. RBC Capital Markets reiterated a “sector perform” rating and set a $115.00 target price (down previously from $121.00) on shares of Clorox in a research report on Thursday, November 3rd. Finally, Royal Bank Of Canada decreased their target price on Clorox from $121.00 to $115.00 and set a “sector perform” rating on the stock in a research report on Thursday, November 3rd. Two analysts have rated the stock with a sell rating, ten have given a hold rating and one has issued a buy rating to the stock. Clorox presently has a consensus rating of “Hold” and an average price target of $127.30.

In related news, EVP Laura Stein sold 38,882 shares of the company’s stock in a transaction on Friday, September 2nd. The stock was sold at an average price of $131.69, for a total transaction of $5,120,370.58. Following the transaction, the executive vice president now owns 48,501 shares of the company’s stock, valued at $6,387,096.69. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, SVP Jon M. Balousek sold 5,136 shares of the company’s stock in a transaction on Monday, August 29th. The stock was sold at an average price of $131.14, for a total value of $673,535.04. Following the transaction, the senior vice president now directly owns 15,384 shares in the company, valued at approximately $2,017,457.76. The disclosure for this sale can be found here. Corporate insiders own 0.74% of the company’s stock.

About Clorox

Related posts

Leave a Comment